Bird & Bird advises Canaccord Genuity Limited on Kore Potash's London IPO

Bird & Bird's London Capital Markets team advised Canaccord Genuity Limited as nominated adviser and broker on the initial public offering of Kore Potash plc on the AIM Market of the London Stock Exchange, with a market cap of AUS$92.6m. 

Kore Potash is an advanced stage potash exploration and development company whose primary project is located in the Republic of Congo. Kore is already listed on the Australian Stock Exchange and was also admitted to the main board of the Johannesburg Stock Exchange.

The team was led by Corporate Partner Clive Hopewell and assisted by associates Sharon O'Donnell, Sarforaz Hoque and Freddie Spearman. 

Clive Hopewell said: "We were thrilled to advise our longstanding client Canaccord Genuity on the IPO of Kore Potash. The listing follows a trend we've been seeing over the last two  years of Australian listed companies seeking dual listings in London in order to tap into the substantial institutional pools of capital. With market leading practices based in both Sydney and London, Bird & Bird's international Capital Markets group is extremely well placed to handle these types of transactions."

The firm has acted for some of the world's leading mining companies, particularly in relation to specialist areas such as engineering, technology and IT. This deal further supports the firm's wider strategy of expanding its client base in the Mining and Minerals industry, as part of its market leading Energy and Utilities sector group. It also demonstrates Bird & Bird's growing Africa practice.

News & Deals

More News & Deals
Deal Bird & Bird advises shareholders of The Payments Association on partnership with Nineteen Group

Aug 07 2025

Read More
News Bird & Bird boosts Dispute Resolution team in Singapore

Aug 06 2025

Read More
Deal Bird & Bird acts for Cornerstone Investors in US$140m placing by Rockhopper Exploration

Aug 06 2025

Read More
Deal Bird & Bird advises ACTUM Digital on Strategic Acquisition of Kuehlhaus AG

Aug 05 2025

Read More
News Bird & Bird Advises Ratiopharm in Landmark Xarelto Patent Revocation Case

Aug 01 2025

Read More
Deal Bird & Bird advises Everystate on its seed funding round

Jul 30 2025

Read More

Related capabilities